Cieplak W, Hart D A
Thromb Haemost. 1985 Feb 18;53(1):36-41.
Human urine was found to contain multiple species of urokinase (UK)-like plasminogen activator (PA) activity when subjected to concentration and/or dialysis and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and zymography. Untreated, freshly voided urine contained only Mr = 52,000 and 35,000 UK while dialyzed or undialyzed urine concentrates contained additional PA activity at Mr = 80,000 and 95,000. SDS-PAGE of incubation mixtures of radioiodinated UK (Mr = 52,000 or 35,000) and urine concentrates revealed the presence of radiolabeled complexes with Mrs of 80,000 and 95,000. The bond(s) involved in complex formation was also relatively resistant to heat and reduction. Treatment of radioiodinated UK with the serine proteinase inhibitor, p-nitrophenyl guanidinobenzoate, prior to incubation with dialyzed, concentrated urine prevented formation of the complexes. In addition, the enzymatic activity of the Mr = 80,000 and 95,000 species was unaffected by diisopropyl fluorophosphate. These results indicate that UK forms SDS-stable complexes with a urinary component that has a Mr of approximately 40,000. The results further suggest that these complexes express PA activity when analyzed by SDS-PAGE and zymography.
当对人尿液进行浓缩和/或透析,并用十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)和酶谱法分析时,发现其中含有多种类尿激酶(UK)样纤溶酶原激活剂(PA)活性。未经处理的新鲜晨尿仅含有分子量为52,000和35,000的UK,而透析或未透析的尿液浓缩物中还含有分子量为80,000和95,000的额外PA活性。对放射性碘标记的UK(分子量为52,000或35,000)与尿液浓缩物的孵育混合物进行SDS-PAGE分析,发现存在分子量为80,000和95,000的放射性标记复合物。参与复合物形成的键对热和还原剂也具有相对抗性。在用丝氨酸蛋白酶抑制剂对硝基苯基胍基苯甲酸酯处理放射性碘标记的UK后,再与透析后的浓缩尿液孵育,可防止复合物的形成。此外,分子量为80,000和95,000的PA活性不受氟磷酸二异丙酯的影响。这些结果表明,UK与一种分子量约为40,000的尿液成分形成了SDS稳定的复合物。结果还进一步表明,当通过SDS-PAGE和酶谱法分析时,这些复合物具有PA活性。